Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2025-12-27 @ 10:16 PM
Study NCT ID:
NCT00911261
Status:
COMPLETED
Last Update Posted:
2010-02-15
First Post:
2009-05-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
Sponsor:
Endo Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-08
Start Date Type:
None
Primary Completion Date:
2005-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-05
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-15
First Submit QC Date:
None
Study First Post Date:
2009-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-02-12
Last Update Post Date:
2010-02-15
Last Update Post Date Type:
ESTIMATED